The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats

European Journal of Pharmacology

Volumn 528, Issue 1-3, 2005, Pages 103-109

  Magalas, Zofia ^a   De Vry, Jean ^a   Tzschentke, Thomas M ^a  

^a GRÜNENTHAL GMBH   (Germany)

Author keywords

Addiction; Analgesics; Antidepressant; Drug abuse; Operant behaviour; Opioid; Reinforcement

Indexed keywords

DIAMORPHINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ATTENUATION; BEHAVIOR CHANGE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INFUSION; FOOD; MAINTENANCE THERAPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REINFORCEMENT; TASK PERFORMANCE; TRAINING;

ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; CYCLOHEXANOLS; FEEDING BEHAVIOR; HEROIN; HEROIN DEPENDENCE; MALE; RATS; RATS, LONG-EVANS; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 28844464785     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.038     Document Type: Conference Paper

References (41)

1. D.A. Baker, T.L. Tran-Nguyen, R.A. Fuchs, and J.L. Neisewander Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats Psychopharmacology 155 2001 18 26
2. M. Briley Clinical experience with dual action antidepressants in different chronic pain syndromes Hum. Psychopharmacol. Clin. Exp. 19 2004 S21 S25
3. M.E. Carroll, S.T. Lac, M. Asencio, and R. Kragh Fluoxetine reduces intravenous self-administration in rats Pharmacol. Biochem. Behav. 35 1990 237 244
4. M. Collu, A.S. Poggiu, P. Devoto, and G. Serra Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats Eur. J. Pharmacol. 322 1997 123 127
5. P.S. D'Aquila, M. Collu, P. Devoto, and G. Serra Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D(2)-like receptor agonist quinpirole Eur. J. Pharmacol. 395 2000 157 160
6. P.S. D'Aquila, A.T. Peana, F. Panin, C. Grixoni, M. Cossu, and G. Serra Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal Eur. J. Pharmacol. 458 2003 129 134
7. J.D. Delisle A case of amitriptyline abuse Am. J. Psychiatry 148 1991 297 298
8. J. De Vry, I. Donselaar, and J.M. van Ree Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol J. Pharmacol. Exp. Ther. 251 1989 735 740
9. J. De Vry, I. Donselaar, and J.M. van Ree Intraventricular self-administration of heroin in the rat: reward seems dissociated from analgesia and physical dependence Eur. J. Pharmacol. 161 1989 19 25
10. R.W. Foltin, A.S. Ward, E.D. Collins, M. Haney, C.L. Hart, and M.W. Fischman The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans Exp. Clin. Psychopharmacol. 11 2003 123 130
11. A.A. Harrison, and A. Markou Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors J. Pharmacol. Exp. Ther. 297 2001 316 325
12. D. Hervé, V.M. Pickel, T.H. Joh, and A. Beaudet Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurones Brain Res. 435 1987 71 83
13. S. Iyengar, A.A. Webster, S.K. Hemrick-Luecke, J.Y. Xu, and R.M.A. Simmons Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats J. Pharmacol. Exp. Ther. 311 2004 576 584
14. S.W. Johnson, and R.A. North Opioids excite dopamine neurons by polarization of local interneurons J. Neurosci. 12 1992 483 488
15. M.A. Landabaso, I. Iraurgi, J.M. Jimenez-Lerma, J. Sanz, C. Fernandez, K. Araluce, R. Calle, and M. Gutierrez-Fraile A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts Addiction 93 1998 739 744
16. A.D. Le, C.X. Poulos, S. Harding, J. Watchus, W. Juzytsch, and Y. Shaham Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress Neuropsychopharmacology 21 1999 435 444
17. K. Lee, and C. Kornetsky Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation Pharmacol. Biochem. Behav. 60 1998 539 544
18. L. Lu, W.J. Su, W. Yue, X. Ge, F. Su, G. Pei, and L. Ma Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor Life Sci. 69 2001 37 46
19. W.H. Lyness, and F.L. Smith Influence of dopaminergic and serotonergic neurons on intravenous ethanol self-administration in the rat Pharmacol. Biochem. Behav. 42 1992 187 192
20. R.T. Malseed, and F.J. Goldstein Enhancement of morphine analgesia by tricyclic antidepressants Neuropharmacology 18 1979 827 829
21. W.R. Martin Pharmacology of opioids Pharmacol. Rev. 35 1983 283 323
22. S. Maurel, J. De Vry, and R. Schreiber 5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat Eur. J. Pharmacol. 370 1999 217 223
23. S. Maurel, J. De Vry, and R. Schreiber Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats Alcohol 17 1999 195 201
24. D. Mochizucki Serotonin and noradrenaline reuptake inhibitors in animal models of pain Hum. Psychopharmacol. Clin. Exp. 19 2004 S15 S19
25. S. Morishita, and S. Arita Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression Hum. Psychopharmacol. 18 2003 479 482
26. C.A. Naranjo, C.X. Poulos, K.E. Bremner, and K.L. Lanctot Fluoxetine attenuates alcohol intake and desire to drink Int. Clin. Psychopharmacol. 9 1994 163 172
27. L.A. Pagliaro, and A.M. Pagliaro Fluoxetine abuse by an intravenous drug user Am. J. Psychiatry 150 1898
28. C.A. Paladini, and J.T. Williams Noradrenergic inhibition of midbrain dopamine neurons J. Neurosci. 24 2004 4568 4575
29. A.E. Panerai, M. Bianchi, P. Sacerdote, C. Ripamonti, V. Ventafridda, and F. De Conno Antidepressants in cancer pain J. Palliat. Care 7 1991 42 44
30. M. Papp, R. Muscat, and P. Willner Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist Eur. Neuropsychopharmacol. 2 1992 121 125
31. O.T. Phillipson Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat J. Comp. Neurol. 187 1979 117 143
32. S. Prisco, and E. Esposito Differential effects of acute and chronic fluoxetine administration on the sponteneous activity of dopaminergic neurones in the ventral tegmental area Br. J. Pharmacol. 116 1995 1923 1931
33. S. Prisco, S. Pagannone, and E. Esposito Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo J. Pharmacol. Exp. Ther. 271 1994 83 90
34. A.S. Rauhut, S.N. Mullins, L.P. Dwoskin, and M.T. Bardo Reboxetine: attenuation of intravenous nicotine self-administration in rats J. Pharmacol. Exp. Ther. 303 2002 664 672
35. N.R. Richardson, and D.C.S. Roberts Progressive ratio schedules in drug self-administration studies inrats: a method to evaluate reinforcing efficacy J. Neurosci. Methods 66 1996 1 11
36. C. Stein Opioids in Pain Control. Basic and Clinical Aspects 1999 Cambridge University Press Cambridge, UK
37. J. Stewart, and H. Rajabi Initial increases in extracellular dopamine in the ventral tegmental area provide a mechanism for the development of desipramine-induced sensitization within the midbrain dopamine system Synapse 23 1996 258 264
38. F. Subhan, P.N. Deslandes, D.M. Pache, and R.D.E. Sewell Do antidepressants affect motivation in conditioned place preference? Eur. J. Pharmacol. 408 2000 257 263
39. F. Subhan, D.M. Pache, and R.D.E. Sewell Potentiation of opioid-induced place preference by the selective serotonin reuptake inhibitor fluoxetine Eur. J. Pharmacol. 390 2000 137 143
40. T.M. Tzschentke NA and 5-HT reuptake inhibitors and α2 agonists H. Buschmann Analgesics - From chemistry and pharmacology to clinical application 2002 Wiley-VCH Weinheim, Germany 265 284
41. D.S. Yu, F.L. Smith, D.G. Smith, and W.H. Lyness Fluoxetine-induced attenuation of amphetamine self-administration in rats Life Sci. 39 1986 1383 1388